StockData
Organogenesis Holdings Inc. logo

Organogenesis Holdings Inc. (ORGO) stock

ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$0.85+0.04 (+5.13%)

Close on Nov 18, 2026Market cap $109.79MP/E –Yield –

Organogenesis revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Organogenesis's revenue for the twelve months ending Jun 30, 2026 was $457.45M, up 6.5% year over year. For fiscal 2025 it was $564.17M, up 17.0% from the year before. The highest annual figure on record is $564.17M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$564.17M+17.0%
FY2024Dec 31, 2024$482.04M+11.3%
FY2023Dec 31, 2023$433.14M-3.9%
FY2022Dec 31, 2022$450.89M-3.5%
FY2021Dec 31, 2021$467.36M+38.2%
FY2020Dec 31, 2020$338.30M+29.6%
FY2019Dec 31, 2019$260.98M+34.9%
FY2018Dec 31, 2018$193.45M-2.5%
FY2017Dec 31, 2017$198.51M+43.1%
FY2016Dec 31, 2016$138.73M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$43.76M-56.7%
Q1 FY2026Mar 31, 2026$37.23M-57.1%
Q4 FY2025Dec 31, 2025$225.61M+78.1%
Q3 FY2025Sep 30, 2025$150.86M+31.0%
Q2 FY2025Jun 30, 2025$101.01M-22.4%
Q1 FY2025Mar 31, 2025$86.69M-21.2%
Q4 FY2024Dec 31, 2024$126.66M+27.1%
Q3 FY2024Sep 30, 2024$115.18M+6.1%
Q2 FY2024Jun 30, 2024$130.23M+11.0%
Q1 FY2024Mar 31, 2024$109.98M+2.2%
Q4 FY2023Dec 31, 2023$99.65M-13.7%
Q3 FY2023Sep 30, 2023$108.53M-7.1%
Q2 FY2023Jun 30, 2023$117.32M-3.4%
Q1 FY2023Mar 31, 2023$107.64M+10.8%
Q4 FY2022Dec 31, 2022$115.52M-9.7%
Q3 FY2022Sep 30, 2022$116.86M+2.7%
Q2 FY2022Jun 30, 2022$121.40M-1.5%
Q1 FY2022Mar 31, 2022$97.12M-5.3%
Q4 FY2021Dec 31, 2021$127.86M+19.7%
Q3 FY2021Sep 30, 2021$113.75M+12.9%
Q2 FY2021Jun 30, 2021$123.20M+78.6%
Q1 FY2021Mar 31, 2021$102.55M+66.1%
Q4 FY2020Dec 31, 2020$106.81M+43.1%
Q3 FY2020Sep 30, 2020$100.80M+56.8%
Q2 FY2020Jun 30, 2020$68.96M+6.2%
Q1 FY2020Mar 31, 2020$61.73M+8.1%
Q4 FY2019Dec 31, 2019$74.65M+17.4%
Q3 FY2019Sep 30, 2019$64.27M+26.6%
Q2 FY2019Jun 30, 2019$64.95M+49.1%
Q1 FY2019Mar 31, 2019$57.12M+60.8%
Q4 FY2018Dec 31, 2018$63.60M+19.7%
Q3 FY2018Sep 30, 2018$50.77M-1.3%
Q2 FY2018Jun 30, 2018$43.55M-19.5%
Q1 FY2018Mar 31, 2018$35.53M-10.8%
Q4 FY2017Dec 31, 2017$53.14M-61.7%
Q3 FY2017Sep 30, 2017$51.46M–
Q2 FY2017Jun 30, 2017$54.07M–
Q1 FY2017Mar 31, 2017$39.84M–
Q4 FY2016Dec 31, 2016$138.73M–

More Organogenesis figures

See a number that looks wrong?